Mainz Biomed Announces Petra Smeltzer Starke as Brand Ambassador

Mainz Biomed N.V., a molecular genetics diagnostic company, has announced Petra Smeltzer Starke as its new Brand Ambassador. Starke's role will focus on raising awareness about Mainz Biomed’s products and the importance of early cancer detection.

This strategic alliance is poised to leverage Starke's extensive experience, including her tenure as a Senior Adviser at the White House. CEO Guido Baechler emphasized that her expertise will be vital for the upcoming market introduction of their new colorectal cancer screening product, aimed at a pivotal PMA trial by the end of 2025.

Expressing her enthusiasm, Starke noted her commitment to advancing the early detection of colorectal cancer, particularly identifying pre-cancerous polyps.